Yuhan Corp Preferred (000105) - Net Assets
Based on the latest financial reports, Yuhan Corp Preferred (000105) has net assets worth ₩2.22 Trillion KRW (≈ $1.50 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩3.05 Trillion ≈ $2.07 Billion USD) and total liabilities (₩836.23 Billion ≈ $566.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000105 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩2.22 Trillion |
| % of Total Assets | 72.61% |
| Annual Growth Rate | 5.36% |
| 5-Year Change | 16.47% |
| 10-Year Change | 57.68% |
| Growth Volatility | 4.0 |
Yuhan Corp Preferred - Net Assets Trend (2014–2024)
This chart illustrates how Yuhan Corp Preferred's net assets have evolved over time, based on quarterly financial data. Also explore Yuhan Corp Preferred assets under control for the complete picture of this company's asset base.
Annual Net Assets for Yuhan Corp Preferred (2014–2024)
The table below shows the annual net assets of Yuhan Corp Preferred from 2014 to 2024. For live valuation and market cap data, see Yuhan Corp Preferred (000105) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩2.15 Trillion ≈ $1.46 Billion |
+8.42% |
| 2023-12-31 | ₩1.98 Trillion ≈ $1.34 Billion |
-1.20% |
| 2022-12-31 | ₩2.01 Trillion ≈ $1.36 Billion |
+3.71% |
| 2021-12-31 | ₩1.94 Trillion ≈ $1.31 Billion |
+4.84% |
| 2020-12-31 | ₩1.85 Trillion ≈ $1.25 Billion |
+11.91% |
| 2019-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
-0.11% |
| 2018-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
+2.83% |
| 2017-12-31 | ₩1.61 Trillion ≈ $1.09 Billion |
+7.34% |
| 2016-12-31 | ₩1.50 Trillion ≈ $1.01 Billion |
+9.72% |
| 2015-12-31 | ₩1.36 Trillion ≈ $924.32 Million |
+6.90% |
| 2014-12-31 | ₩1.28 Trillion ≈ $864.64 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Yuhan Corp Preferred's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 70.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩2.01 Trillion | 95.69% |
| Other Components | ₩90.52 Billion | 4.31% |
| Total Equity | ₩2.10 Trillion | 100.00% |
Yuhan Corp Preferred Competitors by Market Cap
The table below lists competitors of Yuhan Corp Preferred ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DANIEL THWAITES LS-25
F:7KW
|
$59.62 Million |
|
The Intergroup Corporation
NASDAQ:INTG
|
$59.65 Million |
|
Onward Technologies Limited
NSE:ONWARDTEC
|
$59.65 Million |
|
Jati Tinggi Group Berhad
KLSE:0292
|
$59.66 Million |
|
Ekinops SA
PA:EKI
|
$59.59 Million |
|
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
|
$59.58 Million |
|
KB No.2 Special Purpose Acq
KQ:192250
|
$59.57 Million |
|
UIL Co. Ltd
KQ:049520
|
$59.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yuhan Corp Preferred's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,983,710,622,800 to 2,100,543,104,230, a change of 116,832,481,430 (5.9%).
- Net income of 70,687,449,390 contributed positively to equity growth.
- Dividend payments of 32,145,147,300 reduced retained earnings.
- Share repurchases of 2,512,349,430 reduced equity.
- Other factors increased equity by 80,802,528,770.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩70.69 Billion | +3.37% |
| Dividends Paid | ₩32.15 Billion | -1.53% |
| Share Repurchases | ₩2.51 Billion | -0.12% |
| Other Changes | ₩80.80 Billion | +3.85% |
| Total Change | ₩- | 5.89% |
Book Value vs Market Value Analysis
This analysis compares Yuhan Corp Preferred's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.69x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.95x to 2.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩25980.93 | ₩76600.00 | x |
| 2018-12-31 | ₩26767.73 | ₩76600.00 | x |
| 2019-12-31 | ₩26904.01 | ₩76600.00 | x |
| 2020-12-31 | ₩30079.63 | ₩76600.00 | x |
| 2021-12-31 | ₩28584.38 | ₩76600.00 | x |
| 2022-12-31 | ₩28206.83 | ₩76600.00 | x |
| 2023-12-31 | ₩26868.55 | ₩76600.00 | x |
| 2024-12-31 | ₩28464.98 | ₩76600.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yuhan Corp Preferred utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.42%
- • Asset Turnover: 0.70x
- • Equity Multiplier: 1.40x
- Recent ROE (3.37%) is below the historical average (6.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 7.13% | 8.94% | 0.63x | 1.27x | ₩-36.52 Billion |
| 2015 | 9.25% | 11.17% | 0.60x | 1.38x | ₩-10.23 Billion |
| 2016 | 10.77% | 12.21% | 0.65x | 1.37x | ₩11.59 Billion |
| 2017 | 6.81% | 7.46% | 0.70x | 1.31x | ₩-50.96 Billion |
| 2018 | 3.50% | 3.78% | 0.70x | 1.32x | ₩-106.69 Billion |
| 2019 | 2.43% | 2.70% | 0.70x | 1.29x | ₩-124.62 Billion |
| 2020 | 10.48% | 11.90% | 0.68x | 1.30x | ₩8.75 Billion |
| 2021 | 5.32% | 6.08% | 0.69x | 1.28x | ₩-90.10 Billion |
| 2022 | 4.79% | 5.36% | 0.72x | 1.25x | ₩-103.44 Billion |
| 2023 | 6.87% | 7.33% | 0.77x | 1.21x | ₩-62.17 Billion |
| 2024 | 3.37% | 3.42% | 0.70x | 1.40x | ₩-139.37 Billion |
Industry Comparison
This section compares Yuhan Corp Preferred's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $262,656,911,003
- Average return on equity (ROE) among peers: 0.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yuhan Corp Preferred (000105) | ₩2.22 Trillion | 7.13% | 0.38x | $59.61 Million |
| Dongwha Pharm.Co.Ltd (000020) | $252.93 Billion | 10.38% | 0.28x | $113.83 Million |
| Yuhan Corp. (000100) | $407.93 Billion | 10.79% | 0.55x | $4.57 Billion |
| Yuyu Pharma (000220) | $69.50 Billion | 3.97% | 0.28x | $46.55 Million |
| Yuyu Pharma Inc (000225) | $117.04 Billion | 1.10% | 0.32x | $17.67 Million |
| Yuyu Pharma Inc (000227) | $78.29 Billion | 7.52% | 0.42x | $42.93 Million |
| Ildong Holdings Co Ltd (000230) | $169.10 Billion | -60.53% | 4.10x | $76.14 Million |
| Samil Pharm (000520) | $127.83 Billion | 1.30% | 1.90x | $127.90 Million |
| Donga Socio Holdings (000640) | $875.86 Billion | 17.02% | 0.60x | $427.15 Million |
| Jw Pharmac (001060) | $265.44 Billion | 13.94% | 1.43x | $476.78 Million |
About Yuhan Corp Preferred
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.